Position in ABCL
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,678,584
-$1,556,004 QoQ
Shares Held
595,998
-66.6% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#23
of 150 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Guardian Partners Inc. holds $5,886,181 across 6 Biotechnology names. ABCL ranks #1 (79.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
This page
|
595,998 | $4,678,584 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
4,500 | $842,760 | |
| 3 | ABVX |
Abivax S.A.
|
2,700 | $359,802 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
66 | $3,104 | |
| 5 | ATAI |
AtaiBeckley Inc.
|
295 | $1,554 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
21 | $377 |
All Filings in ABCL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,678,584 | 595,998 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,234,588 | 1,786,415 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $6,109,535 | 1,786,414 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,985,662 | 1,786,414 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,127,400 | 1,786,414 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,983,703 | 1,786,414 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $5,234,193 | 1,786,414 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||